Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Actavis deal for Allergan would be huge bet on branded drugs
Yahoo/Reuters
Wednesday, October 8, 2014 - 8:31pm
tags:
Actavis, Allergan, M&A
Ebola Drug Stocks React Wildly to Dallas Patient Death
24/7 Wall St
Wednesday, October 8, 2014 - 2:43pm
tags:
ebola virus, Tekmira, Biocryst, Chimerix, Sarepta Therapeutics
This CEO wants us to know as much about our bodies as we do about our credit cards
Fortune
Wednesday, October 8, 2014 - 2:39pm
tags:
Theranos, diagnostics
Dealpolitik: Allergan Battle May Showcase Unintended Consequences of Inversion Rules
WSJ Online
Wednesday, October 8, 2014 - 1:10pm
tags:
Allergan, Valeant Pharmaceuticals, M&A, tax inversions
Does Gilead Sciences Have a European Problem?
Barron's
Wednesday, October 8, 2014 - 1:07pm
tags:
Gilead Sciences, Europe, Sovaldi
FDA accepts sBLA for Lucentis label expansion
Seeking Alpha
Wednesday, October 8, 2014 - 1:06pm
tags:
FDA, Lucentis, Roche, Genentech, diabetic retinopathy
Cardiology groups endorse AZ's Brilinta over Plavix
Medical Marketing and Media
Wednesday, October 8, 2014 - 11:07am
tags:
AstraZeneca, cardiologists, Brilinta, Plavix
Salix’s Xifaxan Sales Expected To Go Downhill
Bidness Etc.
Wednesday, October 8, 2014 - 11:04am
tags:
Salix, Xifaxan, hepatitis C
Arrowhead Sinks on Disappointing Hepatitis B Drug Data
TheStreet.com
Wednesday, October 8, 2014 - 10:53am
tags:
Arrowhead Research, hepatitis B, ARC-520
Tekmira CEO says being a biotech is like being in ‘shark-infested water’
Marketwatch
Wednesday, October 8, 2014 - 10:51am
tags:
Tekmira Pharmaceuticals, Pharma CEOs
Phase 3 successful for Amgen's adalimumab biosimilar
Seeking Alpha
Wednesday, October 8, 2014 - 10:09am
tags:
Amgen, adalimumab, biosimilars, Humira, ABP 501
Chimerix drug used for Ebola shows promise in respiratory cases
Reuters
Wednesday, October 8, 2014 - 10:04am
tags:
Chimerix, ebola virus, adenovirus, Brincidofovir
Safety advocates seek stronger warnings on Chantix
Yahoo/AP
Wednesday, October 8, 2014 - 9:52am
tags:
Chantix, Pfizer, smoking cessation, FDA
Is The Pharma Industry Overvalued?
Bidness Etc.
Wednesday, October 8, 2014 - 7:45am
tags:
pharma stocks
Novartis says 3 executives to leave after GSK, Lilly deals
Yahoo/Reuters
Wednesday, October 8, 2014 - 7:31am
tags:
Novartis, GSK, Eli Lilly
[video]Actavis plans new Allergan approach: Report
CNBC
Tuesday, October 7, 2014 - 4:53pm
tags:
Actavis, Allergan, M&A, Valeant Pharmaceuticals
Salix: The Field of Potential Buyers is Vast, Analyst Says
WSJ Online
Tuesday, October 7, 2014 - 4:52pm
tags:
Salix, M&A, Actavis, Allergan, AstraZeneca, Takeda
The Battle For Lung Cancer Drugs Continues
Bidness Etc.
Tuesday, October 7, 2014 - 1:45pm
tags:
lung cancer, AstraZeneca, Clovis Oncology, AZD9291, CO-1686
Gilead Sciences: Here Comes the Competition
Barron's
Tuesday, October 7, 2014 - 1:21pm
tags:
Gilead Sciences, hepatitis C, Sovaldi, Merck, AbbVie, Idenix, Bristol-Myers Squibb, Achillion
$1.1 billion in drug, device payments to doctors not included in new federal database
Mass Device
Tuesday, October 7, 2014 - 12:24pm
tags:
physicial payments, Physician Payment Sunshine Act, devices

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.